Inhibition by N-(phosphonacetyl)-L-aspartate of aspartate transcarbamylase activity and drug-induced cell proliferation in mice.
D000284:Administration, Oral; D000818:Animals; D001221:Aspartate Carbamoyltransferase / Q000037:antagonists & inhibitors*; D001224:Aspartic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology; D002250:Carbon Radioisotopes; D002455:Cell Division / Q000187:drug effects*; D004247:DNA / Q000096:biosynthesis; D005260:Female; D007279:Injections, Subcutaneous; D007545:Isoproterenol / Q000494:pharmacology; D007583:Jejunum / Q000187:drug effects / Q000201:enzymology; D051379:Mice; D063065:Organophosphonates / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*; D010746:Phosphonoacetic Acid / Q000031:analogs & derivatives; D013154:Spleen / Q000187:drug effects / Q000201:enzymology* / Q000378:metabolism; D013363:Submandibular Gland / Q000187:drug effects / Q000378:metabolism; D013936:Thymidine / Q000378:metabolism; D013997:Time Factors; D014316:Tritium
D002250:Carbon Radioisotopes; D063065:Organophosphonates; D014316:Tritium; D001224:Aspartic Acid; C013195:sparfosic acid; D004247:DNA; D001221:Aspartate Carbamoyltransferase; D007545:Isoproterenol; D010746:Phosphonoacetic Acid; D013936:Thymidine